Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Feb;23(2):222-3.
doi: 10.1038/mt.2014.251.

Therapeutic implications of orally delivered immunomodulatory oligonucleotides

Dennis M Klinman  1
Affiliations
Comment

Therapeutic implications of orally delivered immunomodulatory oligonucleotides

Dennis M Klinman. Mol Ther. 2015 Feb.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov. 2006;5:471–484. - PubMed
    1. Klinman DM, Tross D, Klaschik S, Shirota H., and, Sato T. Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides. Ann NY Acad Sci. 2009;1175:80–88. - PubMed
    1. Wang Y, Yamamoto Y, Shigemori S, Watanabe T, Oshiro K, Wang X.et al. (2015Inhibitory/suppressive oligodeoxynucleotide nanocapsules as simple oral delivery devices for preventing atopic dermatitis in mice Mol Ther 23297–309. - PMC - PubMed
    1. Klinman DM. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol. 2004;4:249–258. - PubMed
    1. Ito Y, Shigemori S, Sato T, Shimazu T, Hatano K, Otani H.et al. (2013Class I/II hybrid inhibitory oligodeoxynucleotide exerts Th1 and Th2 double immunosuppression FEBS Open Bio 341–45. - PMC - PubMed